Active Clinical Trials

Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.

Showing 171 results
  • Sort by Sort ascending
  • Study title
  • Condition
  • Phase
  • Location
Study title Condition Phase Location

Phase I/II Study of Rapcabtagene Autoleucel in CLL, 3L+ DLBCL, r/r ALL and 1L HR LBCL

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Diffuse Large B-cell Lymphoma, Acute Lymphoblastic Leukemia, Large B-cell Lymphoma Phase1, Phase2 United States
Spain
Italy
Japan
Germany
France
Australia
Austria
View All

A Phase I Study of IAG933 in Patients With Advanced Mesothelioma and Other Solid Tumors

Mesothelioma Phase1 United States
Spain
Japan
Germany
United Kingdom
Australia
Italy
Canada
Netherlands
France
Switzerland
View All

A 24-week Study Evaluating the Effectiveness and Safety of Lucentis® 0.2mg in Retinopathy of Prematurity Participants in China

Retinopathy of Prematurity China

Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V

Lupus Nephritis Phase2 Turkey
Israel
United States
China
Germany
Portugal
Hungary
Malaysia
Spain
France
Mexico
India
Hong Kong
Puerto Rico
Brazil
Singapore
View All

Long Term Observational Study to Collect in a Real-world populatIon Data on the Treatment Pattern of secukinumAb in Adult Patients With Moderate to Severe Hidradenitis Suppurativa.

Hidradenitis Suppurativa Germany

Regulatory Post-Marketing Surveillance of Xolair® for Chronic Rhinosinusitis With Nasal Polyps

Chronic Rhinosinusitis With Nasal Polyps Korea, Republic of

A Study to Evaluate the Efficacy and Safety of QMF149 (Indacaterol Acetate/Mometasone Furoate) Versus Budesonide in Children From 6 to Less Than 12 Years of Age With Asthma

Asthma Phase3 Greece
Spain
South Africa
Italy
Colombia
Romania
Hungary
Argentina
Austria
Mexico
Guatemala
Portugal
Panama
Czechia
View All

A Phase I Study of [177Lu]Lu-FF58 in Patients With Advanced Solid Tumors.

Pancreatic Ductal Adenocarcinoma, Gastroesophageal Adenocarcinoma, Glioblastoma Multiforme Phase1 United States
Switzerland
Spain
Netherlands
Italy
Israel
View All

Rollover Study for Patients With Sickle Cell Disease Who Have Completed a Prior Novartis-Sponsored Crizanlizumab Study

Sickle Cell Disease Phase4 United States
Turkey
Spain
Lebanon
Belgium
Colombia
Germany
Oman
Italy
Brazil
View All

CAR-T Long Term Follow Up (LTFU) Study

Long Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access Program Phase3 United States
Spain
Germany
Australia
Japan
Denmark
Belgium
Canada
Finland
United Kingdom
Italy
Norway
France
Israel
Singapore
Taiwan
Netherlands
Austria
View All